Vertex Pharmaceuticals Incorporated
Cambridge, MA (Massachusetts) US
Medicines and Medical Drugs, Pharmaceutical Chemical Research and Development Services...
TEL: +617 444 6100
FAX: +617 444 6680
http://www.vrtx.com
Total : 2 View more »
Cambridge, MA (Massachusetts) US
Medicines and Medical Drugs, Pharmaceutical Chemical Research and Development Services...
TEL: +617 444 6100
FAX: +617 444 6680
http://www.vrtx.com
Cambridge, MA (Massachusetts) US
Medicines and Medical Drugs, Veterinary Medicines or Pharmaceuticals...
TEL: +617 444 6100
FAX: +617 444 6680
http://www.vpharm.com
Total : 104 View more »
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News) today announced that it will webcast its presentations at the
http://finance.yahoo.com/news/Vertex-Pharmaceuticals-bw-2790451287.html?x=0&.v=1
NEW YORK, October 21 (newratings.com) - Analysts at Wedbush Morgan reinitiate coverage of Vertex Pharma (ticker: VRTX) with a "neutral" rating. The target price is set to $42. [more]
http://www.newratings.com/en/main/company_headline.m?id=1979336
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News) today reviewed recent
http://finance.yahoo.com/news/Vertex-Pharmaceuticals-bw-4083515107.html?x=0&.v=1
Total : 36 View more »
CAMBRIDGE, Mass., Oct 30, 2009 (BUSINESS WIRE) --
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at the Oppenheimer 20th Annual Healthcare Conference on Wednesday, November 4, 2009 at 2:10 p.m. EST and at the Credit Suisse 18th Annual Healthcare Conference on Thursday, November 12, 2009 at 7:30 a.m. MST (9:30 a.m. EST).
The presentations will be webcast live and may be accessed from 'Events & Presentations' on the home page of Vertex's website at www.vrtx.com. A replay of the webcasts will also be available on the Company's website for two weeks following each presentation. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex's press releases are available at www.vrtx.com.
(VRTX-WEB)
SOURCE: Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated Lora Pike, 617-444-6755 Associate Director, Investor Relations
Tags: biotechnology cancer conference drugs health nasdaq pharmaceuticals products
Companies: Vertex Pharmaceuticals Inc. (VRTX)
Oct 29, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on October 05, 2009 at $34.57.
Since then, Vertex Pharmaceuticals has returned 4.3% as of today's recent price of $33.10. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq pharmaceuticals profit securities trial
Companies: Vertex Pharmaceuticals Inc. (VRTX)
Oct 26, 2009 (Wall Street Horizon via COMTEX) --
Vertex Pharmaceuticals Incorporated (VRTX)
Expected next earnings release: Announcement date: 10/26/2009 - After Market Earnings Quarter: Q3 Announcement Status: Verified
Expected next investor conference call information: Conference Call Date: 10/26/2009 Conference Call Time (ET): 5:00 PM Conference Call URL: http://investors.vrtx.com/eventdetail.cfm?eventid=73499
Tags: conference corporate earnings market pharmaceuticals
Companies: Vertex Pharmaceuticals Inc. (VRTX)
Oct 20, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on October 05, 2009 at $34.58.
Since then, Vertex Pharmaceuticals has returned 4% as of today's recent price of $33.20. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq pharmaceuticals profit securities trial
Companies: Vertex Pharmaceuticals Inc. (VRTX)
Total : 85 View more »
Copyright © 2009 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
http://www.holdrs.com/holdrs/main/index.asp?Action=Headlines&Description=&Image=&symb=VRTX&sid=7853
in the discovery, development, manufacturing and... and finish drug product processes for protein parenteral products at contract manufacturing sites, in...
This analysis examines the current position and future outlook for Vertex in the emerging biotechnology sector. It encompasses company strategy, comparative portfolio and pipeline analysis and assessment of financial performance, providing 1, 3 and 6 year sales forecasts for key drugs.
For pharmaceutical and biotechnology companies, the development of a new medicine can take more than a decade – a decade of great expense for the developer and of prolonged anxiety for patients in need of new treatments.
Total : 3,590,000 View more »
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases.
Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide.
Research VERTEX PHARMACEUTICALS INC historical prices, historical volume, splits and dividends.
http://finance.aol.com/quotes/vertex-pharmaceuticals-incorporated/vrtx/nas
Our vision is to be a major drug company, setting the standard for pharmaceutical research and development productivity in the 21st century. A vision as great as this can only be ...